General MedicationsSYRINGEStandard
PEGASYS
PEGINTERFERON ALFA-2A
Standard Dose
180U/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PEGASYS is listed in Drugs@FDA under application 103964 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PEGINTERFERON ALFA-2A Form and strength SYRINGE - 180U/5ML Sponsor Pharmaand GmbH Submission history Latest submission status date: 2023-12-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview PEGASYS is listed in Drugs@FDA under application 103964 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient PEGINTERFERON ALFA-2A Form and strength SYRINGE - 180U/5ML Sponsor Pharmaand GmbH Submission history Latest submission status date: 2023-12-11 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.